|
1
|
Simard EP, Ward EM, Siegel R and Jemal A:
Cancers with increasing incidence trends in the United States: 1999
through 2008. CA Cancer J Clin. Jan 4–2012.(Epub ahead of
print).
|
|
2
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009.
|
|
3
|
Olaleye O, Ekrikpo U, Moorthy R, et al:
Increasing incidence of differentiated thyroid cancer in South East
England: 1987–2006. Eur Arch Otorhinolaryngol. 268:899–906.
2011.PubMed/NCBI
|
|
4
|
Capezzone M, Morabito E, Bellitti P,
Giannasio P, De Sanctis D and Bruno R: Increasing incidence of
thyroid cancer in Basilicata: an Italian study. J Endocrinol
Invest. 30:507–512. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smailyte G, Miseikyte-Kaubriene E and
Kurtinaitis J: Increasing thyroid cancer incidence in Lithuania in
1978–2003. BMC Cancer. 6:2842006.PubMed/NCBI
|
|
6
|
Liu S, Semenciw R, Ugnat AM and Mao Y:
Increasing thyroid cancer incidence in Canada, 1970–1996: time
trends and age-period-cohort effects. Br J Cancer. 85:1335–1339.
2001.
|
|
7
|
Xiang J, Wu Y, Li DS, et al: New clinical
features of thyroid cancer in eastern China. J Visc Surg.
147:e53–e56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Finucane MM, Stevens GA, Cowan MJ, et al:
National, regional, and global trends in body-mass index since
1980: systematic analysis of health examination surveys and
epidemiological studies with 960 country-years and 9.1 million
participants. Lancet. 377:557–567. 2011.
|
|
9
|
Wang Y, Mi J, Shan XY, Wang QJ and Ge KY:
Is China facing an obesity epidemic and the consequences? The
trends in obesity and chronic disease in China. Int J Obes (Lond).
31:177–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CM: Overview of obesity in Mainland
China. Obes Rev. 9(Suppl 1): 14–21. 2008. View Article : Google Scholar
|
|
11
|
Khandekar MJ, Cohen P and Spiegelman BM:
Molecular mechanisms of cancer development in obesity. Nat Rev
Cancer. 11:886–895. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: a
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roberts DL, Dive C and Renehan AG:
Biological mechanisms linking obesity and cancer risk: new
perspectives. Annu Rev Med. 61:301–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sweeney G: Leptin signalling. Cell Signal.
14:655–663. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
|
|
17
|
Riolfi M, Ferla R, Del Valle L, et al:
Leptin and its receptor are overexpressed in brain tumors and
correlate with the degree of malignancy. Brain Pathol. 20:481–489.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoon Kim J, Lee SY, Myung SC, Kim YS, Kim
TH and Kim MK: Clinical significance of the leptin and leptin
receptor expressions in prostate tissues. Asian J Androl.
10:923–928. 2008.PubMed/NCBI
|
|
20
|
Uddin S, Bu R, Ahmed M, et al:
Overexpression of leptin receptor predicts an unfavorable outcome
in Middle Eastern ovarian cancer. Mol Cancer. 8:742009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koda M, Sulkowska M, Kanczuga-Koda L,
Surmacz E and Sulkowski S: Overexpression of the obesity hormone
leptin in human colorectal cancer. J Clin Pathol. 60:902–906. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Wan D, Pan Z, et al: Expression and
biological significance of leptin, leptin receptor, VEGF, and CD34
in colorectal carcinoma. Cell Biochem Biophys. 60:241–244. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Uddin S, Bavi P, Siraj AK, et al: Leptin-R
and its association with PI3K/AKT signaling pathway in papillary
thyroid carcinoma. Endocr Relat Cancer. 17:191–202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng SP, Chi CW, Tzen CY, et al:
Clinicopathologic significance of leptin and leptin receptor
expressions in papillary thyroid carcinoma. Surgery. 147:847–853.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koda M, Sulkowska M, Wincewicz A, et al:
Expression of leptin, leptin receptor, and hypoxia-inducible factor
1 alpha in human endometrial cancer. Ann NY Acad Sci. 1095:90–98.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koda M, Sulkowska M, Kanczuga-Koda L, et
al: Expression of the obesity hormone leptin and its receptor
correlates with hypoxia-inducible factor-1 alpha in human
colorectal cancer. Ann Oncol. 18(Suppl 6): vi116–119. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koda M, Kanczuga-Koda L, Sulkowska M,
Surmacz E and Sulkowski S: Relationships between hypoxia markers
and the leptin system, estrogen receptors in human primary and
meta-static breast cancer: effects of preoperative chemotherapy.
BMC Cancer. 10:3202010. View Article : Google Scholar
|
|
28
|
Garofalo C, Koda M, Cascio S, et al:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen C, Chang YC, Liu CL, Chang KJ and Guo
IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is
associated with up-regulation of cyclin D1 and c-Myc and
down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast
Cancer Res Treat. 98:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng SP, Liu CL, Hsu YC, Chang YC, Huang
SY and Lee JJ: Regulation of leptin receptor expression in human
papillary thyroid cancer cells. Biomed Pharmacother. 66:469–473.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng SP, Yin PH, Chang YC, Lee CH, Huang
SY and Chi CW: Differential roles of leptin in regulating cell
migration in thyroid cancer cells. Oncol Rep. 23:1721–1727.
2010.PubMed/NCBI
|
|
32
|
Cheng SP, Yin PH, Hsu YC, et al: Leptin
enhances migration of human papillary thyroid cancer cells through
the PI3K/AKT and MEK/ERK signaling pathways. Oncol Rep.
26:1265–1271. 2011.PubMed/NCBI
|
